Viewing Study NCT00072150


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2025-12-29 @ 4:29 AM
Study NCT ID: NCT00072150
Status: COMPLETED
Last Update Posted: 2013-06-05
First Post: 2003-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module